M&A represents the mergers and acquisitions sector, tracking deal flows and advisory activity across healthcare, biotech, enterprise software, and industrial verticals globally. Q1 2026 saw continued deal momentum in biotech and health services despite broader economic headwinds, with PwC noting active but uncertainty-constrained volumes.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edits, or content requests — sent directly to James.